133 related articles for article (PubMed ID: 37878093)
21. The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia.
El Khoury AC; Pilon D; Morrison L; Shak N; Vermette-Laforme M; Amos TB; Kim E; Lefebvre P
Curr Med Res Opin; 2019 Mar; 35(3):395-405. PubMed ID: 30526125
[TBL] [Abstract][Full Text] [Related]
22. Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents.
Spees LP; Dinan MA; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George DJ; Scales CD; Pritchard JE; Leapman M; Gross CP; Wheeler SB
Clin Genitourin Cancer; 2022 Oct; 20(5):e396-e405. PubMed ID: 35595633
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics.
Xiao Y; Muser E; Fu DJ; Lafeuille MH; Pilon D; Emond B; Wu A; Duh MS; Lefebvre P
Curr Med Res Opin; 2016; 32(4):759-69. PubMed ID: 26750639
[TBL] [Abstract][Full Text] [Related]
24. Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.
Kaye DR; Wilson LE; Greiner MA; Spees LP; Pritchard JE; Zhang T; Pollack CE; George D; Scales CD; Baggett CD; Gross CP; Leapman MS; Wheeler SB; Dinan MA
J Geriatr Oncol; 2022 Jun; 13(5):614-623. PubMed ID: 35125336
[TBL] [Abstract][Full Text] [Related]
25. Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account.
Collado-Borrell R; Escudero-Vilaplana V; Romero-Jiménez R; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Sáez M
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2319-30. PubMed ID: 27316629
[TBL] [Abstract][Full Text] [Related]
26. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma.
Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
JCO Oncol Pract; 2022 Sep; 18(9):e1475-e1483. PubMed ID: 35700416
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
28. Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents.
Jiang Y; Wickersham KE; Zhang X; Barton DL; Farris KB; Krauss JC; Harris MR
Patient Prefer Adherence; 2019; 13():2243-2252. PubMed ID: 32099335
[TBL] [Abstract][Full Text] [Related]
29. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.
Spees LP; Wheeler SB; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George D; Scales CD; Pritchard JE; Leapman M; Gross CP; Dinan MA
Cancer Med; 2021 Oct; 10(19):6653-6665. PubMed ID: 34480518
[TBL] [Abstract][Full Text] [Related]
30. Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting.
Serebruany VL; Tomek A; Kim MH; Litvinov O; Marciniak TA
TH Open; 2017 Jul; 1(2):e101-e105. PubMed ID: 31249915
[No Abstract] [Full Text] [Related]
31. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
32. Eliciting adverse effects data from participants in clinical trials.
Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
[TBL] [Abstract][Full Text] [Related]
33. Analysis of adverse drug events as a way to improve cancer patient care.
Vicente-Oliveros N; Gramage-Caro T; Corral de la Fuente E; Delgado-Silveira E; Álvarez-Díaz AM
Eur J Hosp Pharm; 2023 Dec; 31(1):27-30. PubMed ID: 35332064
[TBL] [Abstract][Full Text] [Related]
34. "Take the tablet or don't take the tablet?"-A qualitative study of patients' experiences of self-administering anti-cancer medications related to adherence and managing side effects.
Dang TH; O'Callaghan C; Alexander M; Burbury K; Jayaraman PP; Wickramasinghe N; Schofield P
Support Care Cancer; 2023 Nov; 31(12):680. PubMed ID: 37934298
[TBL] [Abstract][Full Text] [Related]
35. The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices.
Salgado TM; Mackler E; Severson JA; Lindsay J; Batra P; Petersen L; Farris KB
Support Care Cancer; 2017 Jun; 25(6):1797-1807. PubMed ID: 28108821
[TBL] [Abstract][Full Text] [Related]
36. Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.
Ramos-Ruperez E; Escudero-Vilaplana V; Ruiz-Briones P; Collado-Borrell R; Villanueva-Bueno C; Revuelta-Herrero JL; González-Haba E; Garcia-Gonzalez X; Ibañez-Garcia S; Perez-Ramirez S; Zatarain-Nicolás E; Herranz A; Sanjurjo M
Front Oncol; 2023; 13():1220305. PubMed ID: 37692846
[TBL] [Abstract][Full Text] [Related]
37. Exploring Transplant Medication-Taking Behaviours in Older Adult Kidney Transplant Recipients: A Qualitative Study of Semi-Structured Interviews.
Cossart AR; Staatz CE; Isbel NM; Campbell SB; Cottrell WN
Drugs Aging; 2022 Nov; 39(11):887-898. PubMed ID: 36175739
[TBL] [Abstract][Full Text] [Related]
38. Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States.
Wilson LE; Spees L; Pritchard J; Greiner MA; Scales CD; Baggett CD; Kaye D; George DJ; Zhang T; Wheeler SB; Dinan MA
Kidney Cancer; 2021; 5(3):115-127. PubMed ID: 34632169
[TBL] [Abstract][Full Text] [Related]
39. Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings.
Muluneh B; Muir MA; Collins JB; Proco D; Mackler E; Leak Bryant A; Wood WA; Tilkens M; Reichard JS; Foster M; Gatwood J; Wheeler SB; Zullig LL; Elston Lafata J
PLoS One; 2023; 18(7):e0286630. PubMed ID: 37478078
[TBL] [Abstract][Full Text] [Related]
40. How and Why School Is Important to Teenagers with Cancer: Outcomes from a Photo-Elicitation Study.
Pini S; Gardner P; Hugh-Jones S
J Adolesc Young Adult Oncol; 2019 Apr; 8(2):157-164. PubMed ID: 30300045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
